内核微生物群预测胃肠癌的预后和治疗反应
Jia Liu1, Dongsheng Wei1, Yue Chen2
1State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, Frontiers Science Center for Cell Responses, College of Life Science, Nankai University, Tianjin, China.
这项研究确定了与胃肠癌预后相关的核心肠道微生物群. 使用这种微生物群的新模型可以预测患者的风险,转移和治疗反应,从而推进精确的瘤学.
科学领域:
- 癌症学
- 微生物组研究
- 基因组学
背景情况:
- 瘤相关的微生物群是瘤微环境中的关键,特别是在胃肠癌中.
- 微生物群与瘤生成之间的相互作用及其临床效用需要进一步研究.
研究的目的:
- 在6种胃肠癌类型中全面分析瘤微生物组.
- 开发基于微生物群的预后模型来分层患者并预测结果.
主要方法:
- 在6种胃肠癌类型中对瘤微生物进行了全面分析.
- 开发了一种使用细菌丰度数据来计算风险得分的预测模型.
- 研究了风险得分,转移,信号通路和免疫治疗反应之间的关联.
主要成果:
- 确定了与患者预后相关的15种细菌的核心微生物群.
- 高风险得分与更差的预后,转移的增加 (通过EMT,血管生成,KRAS,TGFβ信号),以及免疫治疗的益处的减少相关.
- 该模型预测了对抗癌药物XL999和tandutinib的敏感性.
结论:
- 基于微生物群的预后模型可以提高胃肠癌的诊断和治疗选择.
- 这种方法通过整合微生物组概况为精确瘤学提供了一种新的策略.
- 这些发现突显了微生物生物标记在风险评估,药物选择和个性化免疫治疗中的潜力.
更多相关视频
08:14A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
Published on: February 28, 2018
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
相关概念视频
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Treatment Resistant Cancers
